HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Gloanec Selected Research

Factor VIIIa

8/2006Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Gloanec Research Topics

Disease

2Hemorrhage
01/2021 - 08/2006
1Pulmonary Embolism
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Stroke (Strokes)
01/2021
1Hemophilia A (Haemophilia)
08/2006

Drug/Important Bio-Agent (IBA)

1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
01/2021
1Serine Proteases (Serine Protease)IBA
08/2006
1Factor VIIIaIBA
08/2006

Therapy/Procedure

1Secondary Prevention
01/2021